RCKT +77% on phase-1 data—despite a public offering being announced before today’s open: https://finance.yahoo.com/news/rocket-pharmaceuticals-announces-positive-gene-210000007.html https://finance.yahoo.com/news/rocket-pharmaceuticals-announces-proposed-public-125100736.html